Aidoc raises $150M Series E led by Goldman Sachs for its CARE foundation model

Aidoc raised a $150M Series E, announced April 29, 2026. Growth Equity at Goldman Sachs Alternatives led. General Catalyst, SoftBank Vision Fund 2 and NVentures, Nvidia's venture arm, participated. Total funding now exceeds $500M.

The company's aiOS platform runs in nearly 2,000 hospitals and analyzes more than 60 million patient cases a year. Its openFDA record shows more than 30 510(k) clearances under the Aidoc name, starting with K180647 in August 2018. The latest before the round was K253578, cleared February 26, 2026. It covers CARE multi-triage on CT for pneumothorax, pericardial effusion, large aortic aneurysm and shoulder fracture or dislocation.

CEO Elad Walach said the money funds new indications, automated draft reports from imaging and global deployment. The company has said it wants end-to-end AI across CT and X-ray within two years. A foundation-model triage product cleared through 510(k), one indication bundle at a time, is the regulatory template other imaging AI companies will copy.